Cardinal Partners


	Alnylam Receives Notice of Allowance from United States Patent and Trademark Office (USPTO) for New Patent Broadly Covering Second Generation Lipid Nanoparticles (LNP) for Systemic Delivery of RNAi Therapeutics
	January 30, 2012
	Verastem, Inc. Announces Pricing of Initial Public Offering
	January 26, 2012
	athenahealth, Inc. Announces Fourth Quarter and Full Year 2011 Earnings Conference Call
	January 23, 2012
	Cubist Pharmaceuticals Reports 2011 Fourth Quarter and Full Year Financial Results
	January 19, 2012
	Alnylam to Restructure Organization, Aligning Resources with Focus on Highest Value Pipeline Opportunities in “Alnylam 5x15™” Product Strategy
	January 19, 2012
	Alnylam Files Patent Infringement Suit Against Tekmira
	January 17, 2012
	Avance Nerve Graft Clinical Results Published
	January 16, 2012
	Alnylam Provides Key 2012 Goals for RNAi Therapeutics Pipeline
	January 08, 2012
	Alnylam Files Clinical Trial Application for ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin for the Treatment of Transthyretin-Mediated Amyloidosis
	January 06, 2012
	Favorable OIG Advisory Opinion Enables Transaction-Based Pricing for the Exchange of Health Information
	January 05, 2012
	Regulus Therapeutics to Present microRNA Platform and Pipeline Updates at Two Leading Scientific Conferences
	January 05, 2012
	Alnylam and Arrowhead Form Collaboration and Licensing Agreement
	January 05, 2012
	Alnylam to Webcast Presentation at 30th Annual J.P. Morgan Healthcare Conference 2012
	January 04, 2012
	Alnylam Reports Positive Preliminary Clinical Results for ALN-PCS, an RNAi Therapeutic Targeting PCSK9 for the Treatment of Severe Hypercholesterolemia
	January 04, 2012
	Alnylam Announces Publication of Pre-clinical Results with ALN-HTT, an RNAi Therapeutic for the Treatment of Huntington's Disease, in Experimental Neurology
	December 28, 2011
	athenahealth to Present at J.P. Morgan Healthcare Conference
	December 28, 2011
	AccentCare Acquires Senior Select and At Home Companions
	December 25, 2011
	Baxter and Momenta Announce Collaboration to Develop and Commercialize Follow-On Biologics
	December 22, 2011
	athenahealth Cloud-Based EHR Service Earns Top National Ranking in 2011 KLAS Report
	December 15, 2011
	athenahealth Provides Fiscal Year 2012 Guidance at Fourth Annual Investor Summit
	December 15, 2011
	Rib-X Reports Positive Top-Line Data from Phase 2b Study of Delafloxacin in Patients with Acute Bacterial Skin and Skin Structure Infections
	December 15, 2011
	aTyr Pharma Appoints Dr. Alan Ezekowitz to Therapeutic Advisory Board
	December 14, 2011
	Cubist Announces First Patient Dosed in Pivotal Global Phase 3 Trial of CXA-201 for Complicated Intra-Abdominal Infections
	December 13, 2011
	Alnylam Scientists Present New Data on RNAi Therapeutics at 53rd ASH Annual Meeting
	December 13, 2011
	Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain Cancer
	December 12, 2011
	Cubist Pharmaceuticals Completes Acquisition of Adolor Corporation
	December 12, 2011
	Nearly 75 percent of women want to breastfeed as long as possible, Philips survey reports
	December 05, 2011
	Momenta Pharmaceuticals Acquires Assets From Virdante Pharmaceuticals
	December 05, 2011
	Philips answers the call for worldwide access to advanced imaging systems for diagnosis and treatment
	November 30, 2011
	Alnylam Completes Enrollment in Phase IIb Study of ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
	November 29, 2011
	Philips MicroDose next generation mammography solution gains traction with first North American customers, enabling excellent image quality at a low radiation dose
	November 29, 2011
	Cubist Pharmaceuticals to Present at December 2011 Investor Conferences
	November 29, 2011
	Momenta Pharmaceuticals to Present at the 2011 Deutsche Bank BioFEST
	November 28, 2011
	Rib-X Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
	November 28, 2011
	Philips’ innovations at RSNA 2011 shape the future of imaging
	November 28, 2011
	Philips customers validate the power of Imaging 2.0 to shape the future of radiology
	November 27, 2011
	Philips introduces Veradius Neo mobile C-arm with flat detector to enhance management of challenging patients and procedures
	November 23, 2011
	New Philips lighting solution increases duration of sleep for hospital patients
	November 22, 2011
	Alnylam to Webcast Presentation at the Piper Jaffray 23rd Annual Health Care Conference
	November 22, 2011
	Alnylam Presents Positive Preliminary Clinical Results for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis
	November 21, 2011
	OhioHealth Expanding Relationship with athenahealth, Selects athenaCommunicator(R)to Enhance Patient Communication and Accessibility
	November 18, 2011
	Philips unveils Integrative Developmental Care model and advances in solutions across the continuum of mother and child care
	November 17, 2011
	Alnylam Pharmaceuticals Grants InterfeRx(TM) Intellectual Property License to Sylentis for Development and Commercialization of RNAi Therapeutics
	November 16, 2011
	Cubist Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of Adolor
	November 15, 2011
	Alnylam to Present Phase I Clinical Data at VIIIth International Symposium on Familial Amyloidotic Polyneuropathy
	November 15, 2011
	Awarepoint Advances Industry Leadership with New Patented Technology
	November 15, 2011
	athenahealth to Host Fourth Annual Investor Summit
	November 15, 2011
	AxoGen to Present at the Lazard Capital Markets 8th Annual Healthcare Conferenc
	November 11, 2011
	The Boston Globe Names athenahealth Among the Top Places to Work in 2011
	November 09, 2011
	AxoGen Reports Third Quarter 2011 Results
	November 09, 2011
	Regulus Therapeutics to Present New In Vivo Data for microRNA-21 in Kidney Fibrosis
	November 08, 2011
	Momenta Pharmaceuticals Reports $1.18 Earnings per Share for the Third Quarter of 2011
	November 07, 2011
	Cubist Pharmaceuticals Commences Tender Offer for All Outstanding Shares of Adolor
	November 07, 2011
	athenahealth Announces Strategic Collaboration with Medley Health
	November 03, 2011
	Verastem, Inc. Files Registration Statement for Proposed Initial Public Offering
	November 03, 2011
	Alnylam and GlaxoSmithKline Form Collaboration on RNAi Technology for Vaccine Production
	November 01, 2011
	Alnylam Pharmaceuticals Reports Third Quarter 2011 Financial Results
	November 01, 2011
	Philips enters North American mammography market, underscoring its global commitment to women’s healthcare
	October 31, 2011
	Cubist Pharmaceuticals to Present at November 2011 Investor Conferences
	October 31, 2011
	Momenta Pharmaceuticals Obtains Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.
	October 28, 2011
	Alnylam to Webcast Conference Call Discussing Third Quarter 2011 Financial Results
	October 25, 2011
	Cubist Pharmaceuticals to Acquire Adolor
	October 24, 2011
	CodeRyte named one of the nation’s fastest growing companies, extends streak to four years
	October 24, 2011
	Webinar Advisory: Regulus to Host Discussion About Potential of microRNA-33 as Target for Treatment of Atherosclerosis
	October 24, 2011
	Momenta Pharmaceuticals Announces That Launch of Authorized Generic Lovenox(R) Triggers Change in Collaboration Terms
	October 24, 2011
	Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Third Quarter 2011 Financial Results
	October 24, 2011
	Rib-X Pharmaceuticals' RX-04 Program Yields Compounds with In Vitro Potency Against Multi-drug Resistant P. aeruginosa
	October 21, 2011
	Cubist to Feature Antibiotic Development Programs at 49th IDSA
	October 20, 2011
	Alnylam to Webcast Presentation at the Newsmakers in the Biotech Industry 2011 Conference
	October 20, 2011
	Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism
	October 20, 2011
	Alexian Brothers Health System Selects athenahealth as Part of New Cloud-Based Clinical Platform to Further Improve Care Coordination
	October 20, 2011
	athenahealth, Inc. Reports Third Quarter Fiscal Year 2011 Results
	October 20, 2011
	Harbin Clinic Expands Relationship with athenahealth: Selects athenaClinicals® for Physician Group
	October 20, 2011
	Cubist Pharmaceuticals Total Net Revenues Top $200 Million for Third Quarter 2011
	October 19, 2011
	Cubist Pharmaceuticals Appoints Jennifer Jackson as Senior Vice President, Regulatory Affairs
	October 17, 2011
	Momenta Pharmaceuticals to Present at the BioCentury NewsMakers Conference
	October 17, 2011
	HealthStar Physicians Selects athenahealth's Cloud-Based Services to Drive Efficiency Across its Network
	October 17, 2011
	Awarepoint Corporation and MEDITECH Collaborate to Integrate Technology Platforms
	October 14, 2011
	athenahealth Launches VaccineViewSM; Reveals that Pediatricians are Reimbursed Below the Full Costs of Certain Vaccinations 47% of the Time
	October 14, 2011
	Alnylam and Collaborators Publish New Pre-clinical Data on Delivery of RNAi Therapeutics to Key Cell Types Regulating Immune and Inflammatory Diseases
	October 11, 2011
	Momenta Pharmaceuticals Obtains Temporary Restraining Order Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.
	October 07, 2011
	Momenta Pharmaceuticals Files for Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.
	September 30, 2011
	Cubist Pharmaceuticals to Move CDAD Candidate into Phase 3
	September 29, 2011
	Alnylam Initiates Phase I Clinical Study of ALN-PCS, an RNAi Therapeutic Targeting PCSK9 for the Treatment of Severe Hypercholesterolemia
	September 26, 2011
	Momenta Pharmaceuticals Sues Amphastar for Patent Infringement
	September 21, 2011
	Alnylam to Webcast Presentation at the JMP Securities Healthcare Conference
	September 21, 2011
	Rib-X Pharmaceuticals Presents Comprehensive Overview of RX-04 Program in 14 Posters at ICAAC
	September 20, 2011
	Momenta Pharmaceuticals to Present at the UBS Global Life Sciences Conference and Pharmaceutical Strategic Alliances Conference
	September 19, 2011
	Cubist Antibiotic Programs Featured in 49 Presentations at 51st ICAAC
	September 15, 2011
	Alnylam to Webcast Presentation at the UBS Global Life Sciences Conference
	September 13, 2011
	Alnylam Scientists and Collaborators Report Significant New Advances in Delivery of RNAi Therapeutics at 2011 Oligonucleotides Therapeutics Society Meeting
	September 13, 2011
	Regulus Therapeutics to Present New Advancements in microRNA Therapeutics for Treatment of Metabolic Diseases and Cancer
	September 08, 2011
	Alnylam Expands 'Alnylam 5x15' RNAi Therapeutic Pipeline with ALN-APC, an RNAi Therapeutic Targeting Protein C for the Treatment of Hemophilia
	September 08, 2011
	Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investment Conferences
	September 08, 2011
	Rib-X Pharmaceuticals to Present 16 Posters Highlighting Data from its Antibiotic Development Programs at ICAAC
	September 08, 2011
	Verastem Appoints José Baselga, M.D., Ph.D., to Scientific Advisory Board
	September 08, 2011
	Alnylam to Webcast Presentation at Upcoming Investor Conferences
	September 07, 2011
	Rib-X Announces Senior Management Promotions
	September 07, 2011
	Rib-X Pharmaceuticals Named a 2011 Fierce 15 Company by FierceBiotech
	September 06, 2011
	Alnylam to Webcast Presentation at the Stifel Nicolaus 2011 Healthcare Conference
	September 01, 2011
	Verastem to Present at the Stifel Nicolaus 2011 Healthcare Conference
	September 01, 2011
	aTyr Pharma Expands Leadership Team to Advance New Breakthrough Medicines Based on Physiocrine Biology
	August 30, 2011
	Cubist Pharmaceuticals to Present at September 2011 Investor Conferences
	August 29, 2011
	Awarepoint Corporation Secures $27 Million in New Financing: Kleiner Perkins Caufield & Byers Leads Round
	August 24, 2011
	Momenta Pharmaceuticals to Present at the 2011 Wedbush Life Sciences Management Access Conference
	August 16, 2011
	FLUIDNET CORPORATION COMPLETES $25 MILLION SERIES C FINANCING
	August 16, 2011
	Athenahealth and Maine Medical Center Physician-Hospital Organization Partner to Improve Health Care
	August 15, 2011
	Cubist Pharmaceuticals and the New England Patriots Radio Network Continue Program to Recognize Innovative Science Teachers
	August 15, 2011
	Momenta Pharmaceuticals to Present at the 2011 Canaccord Genuity Growth Conference
	August 08, 2011
	Medical Image Sharing Now a Top Priority for U.S. Hospitals
	August 08, 2011
	Momenta Pharmaceuticals Reports $1.26 Earnings Per Share for the Second Quarter of 2011
	August 04, 2011
	Verastem Appoints Jonathan Pachter as Head of Research
	August 04, 2011
	Cubist Announces First Patient Dosed in Pivotal Global Phase 3 Trial of CXA-201 for Complicated Urinary Tract Infections
	August 01, 2011
	Alnylam Completes ALN-VSP Phase I Trial in Patients with Liver Cancer
	August 01, 2011
	Cubist Pharmaceuticals to Present at August 2011 Investor Conferences
	July 26, 2011
	Alnylam to Webcast Conference Call Discussing Second Quarter 2011 Financial Results
	July 25, 2011
	Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Second Quarter 2011
	July 25, 2011
	Athenahealth, Inc. Reports Second Quarter Fiscal Year 2011 Results
	July 21, 2011
	Athenahealth to Acquire Proxsys, LLC
	July 21, 2011
	Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment
	July 20, 2011
	Rib-X Pharmaceuticals Receives $9 Million Milestone Payment from Sanofi in the RX-04 Collaboration
	July 19, 2011
	Alnylam and MIT Collaborators Publish Data on Novel Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
	July 19, 2011
	Verastem Raises $32 Million Series B Financing
	July 14, 2011
	Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board
	July 14, 2011
	Cubist Pharmaceuticals 2Q11 Total Net Revenues $176.8 Million
	July 14, 2011
	Alnylam Files Clinical Trial Application (CTA) for ALN-PCS, an RNAi Therapeutic Targeting PCSK9 for the Treatment of Severe Hypercholesterolemia
	July 11, 2011
	University Hospitals' Academic Medical Center Selects athenahealth's Cloud-Based Revenue Cycle Management Service
	July 05, 2011
	Wisconsin's Regional Extension Center Selects athenahealth as an EHR Value Vendor Partner
	July 01, 2011
	Alnylam Files Answer and Counterclaim Related to Tekmira Lawsuit
	June 29, 2011
	Alnylam Presents New Data from ALN-TTR Program at Peripheral Nerve Society Meeting
	June 28, 2011
	World Renowned Specialists Join lifeIMAGE’s Advisory Board
	June 27, 2011
	Cubist Pharmaceuticals Appoints Charles Laranjeira as Senior Vice President, Technical Operations
	June 27, 2011
	Momenta Pharmaceuticals CEO Craig Wheeler Named Ernst & Young Entrepreneur Of The Year(R) 2011 New England Award Winner
	June 21, 2011
	Awarepoint’s Real-time Location and Workflow Solutions have Record Bookings Quarter
	June 20, 2011
	Alnylam Scientists and Collaborators Publish New Article in Nature Describing Discovery of Central Gene in Mitochondrial Physiology
	June 19, 2011
	Cubist Announces Positive Results from Two Phase 2 Trials, CXA-201 and CDAD Program
	June 16, 2011
	Cubist Pharmaceuticals Applauds Congressman Gingrey for Introducing Legislation to Help Fight Superbug Infections
	June 16, 2011
	Awarepoint Chief Medical Officer Harold Koenig to Speak at 2011 Government Health IT Conference & Exhibition
	June 15, 2011
	Verastem to Present at 2011 CEO Biotech Conference
	June 15, 2011
	Rib-X Pharmaceuticals Supports Generating Antibiotic Incentives Now (GAIN) Act
	June 15, 2011
	Henri Termeer Joins Verastem Board of Directors
	June 13, 2011
	Alnylam Appoints Akshay Vaishnaw as Chief Medical Officer
	June 13, 2011
	ASE Partners with lifeIMAGE to Bring Medical Image Sharing Service to Members
	June 13, 2011
	Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes
	June 08, 2011
	Alnylam Provides Organizational Update
	June 07, 2011
	Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33
	June 06, 2011
	Alnylam Presents Phase I Data for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers, at American Society of Clinical Oncology (ASCO) Meeting
	June 04, 2011
	Verastem Co-founder Robert Weinberg to Present Plenary Keynote, 2011 ASCO
	June 03, 2011
	LecTec Corporation Announces Signing of Merger Agreement with AxoGen Inc
	June 02, 2011
	Awarepoint Vice President – Government Business Development Chris Doran to Speak at VHA Real Time Location Systems Conference 2011
	June 01, 2011
	Cubist Pharmaceuticals to Present at June 2011 Investor Conferences
	May 31, 2011
	Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investment Conferences
	May 27, 2011
	athenahealth Begins Collecting EHR “Meaningful Use” Dollars for Physicians
	May 27, 2011
	Momenta Pharmaceuticals Announces Date for 2011 Annual Meeting of Stockholders
	May 25, 2011
	2011 PayerView(R) Rankings Show Correlation between Spread of Electronic Transactions and Faster Claims Processing
	May 25, 2011
	Awarepoint Awarded U.S. Patent for its Revolutionary Tag-to-Tag Communication Technology
	May 24, 2011
	athenahealth Named a 2011 'Best Place to Work' by The Boston Business Journal
	May 23, 2011
	Alnylam to Webcast Presentation at ThinkEquity's 2nd Annual Health Care Conference: A Mid Year Checkup
	May 20, 2011
	HITEC-LA Selects athenahealth as a Preferred Vendor for Certified Electronic Health Records
	May 20, 2011
	Translational Science Expert, Dr. Melissa Ashlock, Joins aTyr Pharma to Advance Physiocrine-based Therapeutics
	May 18, 2011
	Regulus Therapeutics Expands Executive Team with Recent Appointments
	May 18, 2011
	Alnylam's ALN-VSP Abstract Published by American Society of Clinical Oncology (ASCO)
	May 18, 2011
	Awarepoint Expands Senior Management Team
	May 16, 2011
	Momenta Pharmaceuticals Appoints Nic G. Scalfarotto, D.V.M., Vice President of Regulatory Affairs
	May 12, 2011
	Verastem, Inc. Appoints Robert Forrester as Chief Operating Officer
	May 12, 2011
	Rib-X Pharmaceuticals Presents Data at ECCMID for Three Novel Classes of Broad-spectrum Antibiotic Compounds From the RX-04 Development Program
	May 09, 2011
	Rib-X Pharmaceuticals Presents Data at ECCMID Demonstrating Potent In Vitro Activity of Radezolid and Delafloxacin Against Resistant Strains of Gram-positive Bacteria Program
	May 09, 2011
	Dr. Atul Gawande Receives Inaugural athenahealth Vision Award
	May 06, 2011
	Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2011
	May 05, 2011
	Cubist Pharmaceuticals to Present at May Investor Conference
	May 03, 2011
	Cubist Pharmaceuticals’ Antibiotic Programs Featured in 18 Abstracts at 21st ECCMID/27th ICC Joint Congress
	May 02, 2011
	Regulus Therapeutics and Collaborators Present New Results from Preclinical Research on microRNA Therapeutics in Metabolic Disease
	April 28, 2011
	Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investment Conferences
	April 28, 2011
	athenahealth, Inc. Reports First Quarter Fiscal Year 2011 Results
	April 28, 2011
	Alnylam to Webcast Conference Call Discussing First Quarter 2011 Financial Results
	April 27, 2011
	Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for First Quarter 2011 Financial Results
	April 25, 2011
	Precision NanoSystems and Alnylam Form New Delivery Collaboration
	April 19, 2011
	Regulus Therapeutics Appoints Neil W. Gibson, Ph.D., Chief Scientific Officer
	April 18, 2011
	Cubist Pharmaceuticals 1Q11 Total Net Revenues Up 13% to $162.5 Million; 1Q11 U.S. Net Revenues for CUBICIN Up 14% to $153.7 Million
	April 14, 2011
	Regulus Therapeutics and UC San Diego to Collaborate on Angiogenic Disease Research Utilizing microRNA Technology
	April 14, 2011
	Brandon Hull delivers opening address at first annual IBF Digital Health Summit, New York City
	April 14, 2011
	Rib-X Pharmaceuticals to Present at the Future Leaders in the Biotech Industry Conference
	April 13, 2011
	Verastem to Present at the 2011 BD Biotech Conference
	April 07, 2011
	Alnylam Files Answer and Counterclaim Related to Tekmira Lawsuit
	April 06, 2011
	Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (fidaxomicin) for Clostridium difficile Infection in the United States
	April 06, 2011
	athenahealth Selected as a Supported EHR Vendor for the Maine Regional Extension Center
	April 05, 2011
	Cubist Pharmaceuticals Settles CUBICIN Patent Litigation with Teva
	April 04, 2011
	Philips and the American College of Cardiology showcase a new approach to reduce hospital readmissions
	April 04, 2011
	athenahealth Appoints Dr. Todd Rothenhaus to New Chief Medical Information Officer Position
	April 04, 2011
	Alnylam Completes Enrollment in ALN-VSP Phase I Clinical Trial
	March 31, 2011
	AxoGen Announces the Inauguration of Its Social Media Platform
	March 30, 2011
	Alnylam to Webcast Presentation at 10th Annual Needham Healthcare Conference
	March 30, 2011
	Regulus Therapeutics Receives Exclusive License for Intellectual Property to microRNA-33a and microRNA-33b to Treat Diseases that Include Atherosclerosis and Metabolic Syndrome
	March 30, 2011
	Alnylam Achieves Key Technology Transfer Objective in its Takeda Alliance; Earns $10 Million Payment
	March 28, 2011
	AccentCare Moves Corporate Headquarters From California to Dalla
	March 25, 2011
	Regulus Therapeutics Appoints Lars Karlsson, M.D., Ph.D., VP of Immunology and Fibrosis
	March 21, 2011
	Alnylam Responds to Tekmira Complaint
	March 17, 2011
	Rib-X Pharmaceuticals to Present at 13th Annual Superbugs & Superdrugs Conference
	March 16, 2011
	Alnylam Pharmaceuticals Reaches Settlement in Litigation Regarding Tuschl Patents
	March 15, 2011
	Alnylam to Webcast Presentations at Upcoming Investor Conferences
	March 08, 2011
	Cubist Pharmaceuticals Board of Directors Names Kenneth Bate Non-Executive Chair of the Board
	March 07, 2011
	Verastem to Present at the Cowen and Company 31st Annual Health Care Conference
	March 03, 2011
	Alnylam Announces Management Transition in Finance
	March 03, 2011
	Alnylam to Webcast Presentation at 31st Annual Cowen and Company Health Care Conference
	March 02, 2011
	Cubist Pharmaceuticals to Present at March Investor Conference
	March 01, 2011
	aTyr Pharma Announces Formation of Therapeutic Advisory Board
	March 01, 2011
	Regulus Therapeutics Strengthens Strategic Alliance Team Responsible for Managing Productive microRNA Therapeutic Alliances
	February 28, 2011
	Momenta Pharmaceuticals Announces Webcast of Presentations at Upcoming Investment Conferences
	February 23, 2011
	Microsoft and athenahealth Form Strategic Alliance to Launch Clinical Solution to Better Connect Hospitals, Physicians and Patients
	February 22, 2011
	athenahealth/Sermo Physician Sentiment Index (PSI) Finds Value of Electronic Health Records Still More Potential Than Reality
	February 21, 2011
	athenahealth Appoints Stephen Kahane, MD as President of Enterprise Services Group
	February 18, 2011
	Alnylam Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
	February 17, 2011
	athenahealth's EHR Selected as a Five Star Vendor By West Virginia Regional Health Information Technology Extension Center
	February 14, 2011
	Regulus Therapeutics to Present Multiple Platform and Pipeline Advancements at the Keystone Symposium on microRNAs
	February 10, 2011
	Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2010
	February 10, 2011
	Alnylam to Webcast Conference Call Discussing Fourth Quarter and 2010 Financial Results
	February 10, 2011
	Momenta Pharmaceuticals to Present at the Leerink Swann Hot Topics Roundtable Conference
	February 09, 2011
	Momenta Pharmaceuticals Awarded U.S. Patent for Methods of Preparing Glatiramer Acetate
	February 08, 2011
	Cubist Pharmaceuticals to Present at February Investor Conference
	February 08, 2011
	Alnylam to Webcast Presentation at the 13th Annual BIO CEO & Investor Conference
	February 08, 2011
	Rib-X Initiates Phase 2b Study for Broad Spectrum Antibiotic Candidate Delafloxacin in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
	February 08, 2011

Current Portfolio News

Archive Portfolio News